Retrieve available abstracts of 16 articles: HTML format
Single Articles
September 2025
CHUANG PK, Chung C, Liao KS, Wong CH, et al Improving the efficacy of anti-SSEA4 antibody in pancreatic cancer immunotherapy
with glyco-optimization and immune checkpoint blockade.
Proc Natl Acad Sci U S A. 2025;122:e2517415122. PubMedAbstract available
August 2025
YUAN S, Yang X, Bremmer AM, Wang Y, et al Programmable immunoprobiotics orchestrate antitumor immune response with Pin1
inhibition for pancreatic cancer treatment.
Proc Natl Acad Sci U S A. 2025;122:e2507711122. PubMedAbstract available
July 2025
MORESCO P, Kastan JP, Yang JI, Prabakar R, et al Signal peptide-independent secretion of keratin-19 by pancreatic cancer cells.
Proc Natl Acad Sci U S A. 2025;122:e2426218122. PubMedAbstract available
April 2025
VINAIXA J, Martinez-Bosch N, Gibert J, Manero-Ruperez N, et al Nuclear Galectin-1 promotes KRAS-dependent activation of pancreatic cancer
stellate cells.
Proc Natl Acad Sci U S A. 2025;122:e2424051122. PubMedAbstract available
March 2025
ZHU Q, Yu C, Chen Y, Luo W, et al Dual mRNA nanoparticles strategy for enhanced pancreatic cancer treatment and
beta-elemene combination therapy.
Proc Natl Acad Sci U S A. 2025;122:e2418306122. PubMedAbstract available
October 2024
YANG Y, Wang B, Dong H, Lin H, et al The mitochondrial enzyme pyruvate carboxylase restricts pancreatic beta-cell
senescence by blocking p53 activation.
Proc Natl Acad Sci U S A. 2024;121:e2401218121. PubMedAbstract available
August 2024
KITAMURA RA, Hummel D, Ustione A, Piston DW, et al Dual role of neuroplastin in pancreatic beta cells: Regulating insulin secretion and
promoting islet inflammation.
Proc Natl Acad Sci U S A. 2024;121:e2411234121. PubMedAbstract available
SU W, Kochen Rossi J, Nuevo-Tapioles C, Chen T, et al UPF1 deficiency enhances mitochondrial ROS which promotes an immunosuppressive
microenvironment in pancreatic ductal adenocarcinoma.
Proc Natl Acad Sci U S A. 2024;121:e2401996121. PubMedAbstract available
July 2024
AMIT U, Uslu U, Verginadis II, Kim MM, et al Proton radiation boosts the efficacy of mesothelin-targeting chimeric antigen
receptor T cell therapy in pancreatic cancer.
Proc Natl Acad Sci U S A. 2024;121:e2403002121. PubMedAbstract available
LI J, Moresco P, Fearon DT Intratumoral NKT cell accumulation promotes antitumor immunity in pancreatic
cancer.
Proc Natl Acad Sci U S A. 2024;121:e2403917121. PubMedAbstract available
April 2024
HIYOSHI H, Sakuma K, Asano S, Napier SC, et al Identification and removal of unexpected proliferative off-target cells emerging
after iPSC-derived pancreatic islet cell implantation.
Proc Natl Acad Sci U S A. 2024;121:e2320883121. PubMedAbstract available
MURTHY D, Attri KS, Suresh V, Rajacharya GH, et al The MUC1-HIF-1alpha signaling axis regulates pancreatic cancer pathogenesis through
polyamine metabolism remodeling.
Proc Natl Acad Sci U S A. 2024;121:e2315509121. PubMedAbstract available
August 2023
DASGUPTA A, Gibbard DF, Schmitt RE, Arneson-Wissink PC, et al A TGF-beta/KLF10 signaling axis regulates atrophy-associated genes to induce muscle
wasting in pancreatic cancer.
Proc Natl Acad Sci U S A. 2023;120:e2215095120. PubMedAbstract available
May 2023
CHANDA D, Thoudam T, Sinam IS, Lim CW, et al Upregulation of the ERRgamma-VDAC1 axis underlies the molecular pathogenesis of
pancreatitis.
Proc Natl Acad Sci U S A. 2023;120:e2219644120. PubMedAbstract available
March 2023
Correction for Taylor et al., Human pancreatic islet microRNAs implicated in
diabetes and related traits by large-scale genetic analysis.
Proc Natl Acad Sci U S A. 2023;120:e2302726120. PubMed
MELLO SS, Flowers BM, Mazur PK, Lee JJ, et al Multifaceted role for p53 in pancreatic cancer suppression.
Proc Natl Acad Sci U S A. 2023;120:e2211937120. PubMedAbstract available